ConductScience.org, home

Trial · NCT07893106

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAdverse EventsFrom baseline to the end of treatment (up to 10 weeks or Day 70)A summary of AEs, SAEs, and other non-serious adverse events following single oral dose of ASC36 tablets
SecondaryCmax of ASC36 TabletsFrom baseline to the end of treatment (up to 10 weeks or Day 70)Evaluate the peak plasma concentration of ASC36 tablets
SecondaryTmax of ASC36 TabletsFrom baseline to the end of treatment (up to 10 weeks or Day 70)Evaluate the time to reach peak plasma concentration of ASC36 tablets
SecondaryAUC of ASC36 TabletsFrom baseline to the end of treatment (up to 10 weeks or Day 70)Evaluate the area under the plasma concentration-time curve of ASC36 tablets
SecondaryHalf-life of ASC36 TabletsFrom baseline to the end of treatment (up to 10 weeks or Day 70)Evaluate the time required for the plasma concentration of ASC36 to decrease by 50%
SecondaryPercent Change From Baseline in Body WeightFrom baseline to the end of treatment (up to 10 weeks or Day 70)Percent Change From Baseline in Body Weight
SecondaryAbsolute Change From Baseline in Body WeightFrom baseline to the end of treatment (up to 10 weeks or Day 70)Absolute Change From Baseline in Body Weight
SecondaryPercent Change From Baseline in Waist CircumferenceFrom baseline to the end of treatment (up to 10 weeks or Day 70)Percent Change From Baseline in Waist Circumference
SecondaryAbsolute Change From Baseline in Waist CircumferenceFrom baseline to the end of treatment (up to 10 weeks or Day 70)Absolute Change From Baseline in Waist Circumference
SecondaryPercent Change From Baseline in BMIFrom baseline to the end of treatment (up to 10 weeks or Day 70)Percent Change From Baseline in BMI
SecondaryAbsolute Change From Baseline in BMIFrom baseline to the end of treatment (up to 10 weeks or Day 70)Absolute Change From Baseline in BMI

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07893106/registered